MENLO PARK, Calif., April 03, 2023 Sight Sciences, Inc. , an eyecare technology company focused on creating innovative solutions intended to transform care and improve patients’ lives,. | April 3, 2023
Share this article
Share this article
OAKLAND, Calif., Feb. 4, 2021 /PRNewswire/ Koya Medical (www.koyamedical.com), a healthcare company focused on developing breakthrough treatments for lymphedema and venous disorders, announced the appointment of Stanley G. Rockson, MD as its Chief Medical Officer.
Dr. Stanley G. Rockson announced as Chief Medical Officer for Koya Medical.
Dayspring s mobile compression technology provides patients with treatment options that can improve quality of life.
Dr. Stanley G. Rockson is the Professor and Chief of Consultative Cardiology and the Director of the Stanford Center for Lymphatic and Venous Disorders at Stanford University. He is a pioneering leader in the field of lymphedema, co-founder of Lymphatic Education and Research Network (LE&RN) and a Director at the American Board of Venous and Lymphatic Medicine. Dr. Rockson brings over 30 years of leadership and experience in the field.
Koya Medical Closes $11MM Financing to Accelerate Treatment for Lymphedema and Venous Disorders
News provided by
Share this article
Share this article
OAKLAND, Calif., Jan. 14, 2021 /PRNewswire/ Koya Medical (www.koyamedical.com), a healthcare company focused on treating lymphedema and vein disease, today announced the close of a $11 million Series A investment round. The new investment was led by Arboretum Ventures. Jan Garfinkle, founder and managing director of Arboretum Ventures will join the board of directors and Josh Baltzell will continue as the Chairman. Aphelion Capital joins this round along with previous investors including Scientific Health Development Partners, Zühlke Ventures, Bolt, and InnerProduct Partners.